Find uplifting stories about heroes, innovations, and solutions
62 results for "obesity treatment"
Starting June 15, France becomes Europe's first country to fully reimburse medications like Wegovy and Mounjaro. Nearly 10 million French citizens struggling with obesity will now access treatments that previously cost €300 per month.
%2Ffile%2Fattachments%2F2992%2F13971407_975900.jpg)
Starting mid-June, France becomes the first EU nation to reimburse life-changing weight-loss medications for severely obese patients. Up to one million people could access treatments that currently cost €300 monthly out of pocket.
France just became the first EU country to cover breakthrough obesity medications for severely obese patients, helping one million people access treatments that previously cost €300 per month. The bold public health move recognizes obesity as a serious medical condition deserving national support.
A new experimental obesity treatment targeting three hormones has shown significant weight loss in early testing. The "triple-G" drug from Kailera offers fresh hope in the rapidly expanding field of weight management medicine.
NIH researchers have discovered why popular weight loss drugs like Ozempic eventually stop working as well, and they've found a potential way to extend their effectiveness. The breakthrough could help millions push past frustrating plateaus.
NIH researchers discovered why popular GLP-1 medications like Ozempic eventually stop working as well, and they found a possible solution. The breakthrough could help millions push past frustrating weight loss plateaus.
Scientists at UC Riverside discovered that compounds in cannabis beyond THC may help explain why regular users often have lower body weight and diabetes risk. The finding could lead to new treatments that offer metabolic benefits without intoxication.
A groundbreaking medication just moved closer to FDA approval after helping trial participants lose an average of 70 pounds in 80 weeks. The drug matches results typically seen only with surgery, offering new hope for millions struggling with obesity.
A groundbreaking obesity medication helped people lose an average of 70 pounds in clinical trials, matching results previously only seen with bariatric surgery. The drug offers new hope for millions struggling with obesity and related health conditions.
Eli Lilly's experimental obesity medication helped patients lose an average of 28% of their body weight in a major trial, matching results typically seen only with bariatric surgery. The breakthrough treatment offers new hope for millions struggling with obesity, though researchers are working to reduce side effects.
Scientists are testing a breakthrough obesity treatment that helps people lose up to a third of their body weight without sacrificing muscle mass. The triple-action drug retatrutide could solve one of the biggest problems with current weight-loss medications.
A promising triple-action medication could help people lose weight without sacrificing muscle. Retatrutide shows potential for safer weight loss with fewer side effects than earlier medications.
New research shows that people who lost the most weight on GLP-1 medications like Ozempic dramatically reduced their risk of serious health problems. Those who shed at least 15% of their body weight saw sleep apnea risk drop by 69% and kidney disease risk fall by 30%.
The United Arab Emirates just became the first country in the world to approve a groundbreaking hypertension treatment that targets the root causes of high blood pressure. The approval is part of a remarkable year that's positioned the UAE as a global leader in bringing life-changing medicines to patients faster than almost anywhere else.
Scientists have found two promising methods to help people maintain their weight loss after stopping diets or GLP-1 medications like Wegovy. New research shows a daily pill and a probiotic supplement can both help prevent the frustrating cycle of weight regain.
Two major clinical trials show people can maintain their weight loss by switching to lower doses or once-daily pills after initial treatment. The findings offer hope for tackling one of obesity care's biggest challenges: keeping weight off after losing it.
A breakthrough study shows the diabetes drug semaglutide helps older adults lose significant weight safely while improving heart health. Nearly half of participants over 65 achieved at least 15% weight loss in just over a year.
Scientists created a "Trojan horse" drug that delivers double the weight loss power by sneaking extra metabolism boosters directly into cells. Early tests in mice showed stronger results than current treatments, with fewer side effects because it works only where needed.
After 21 years of groundbreaking nutrition research at the NIH, Dr. Kevin Hall retired early but didn't stop fighting to help people understand food and health. He's now designing obesity treatments at a pharmaceutical company and sharing his discoveries in a new book.
Johnson & Johnson's OTTAVA surgical robot just completed its first clinical trial with perfect success, and it fits in operating rooms previously too small for robotic surgery. Five of six hospitals used rooms that had never accommodated surgical robots before.
Showing 20 of 62